000 04467nam a22005895i 4500
999 _c200457982
_d76194
003 DE-He213
005 20231109085847.0
007 cr nn 008mamaa
008 211224s2022 sz | s |||| 0|eng d
020 _a9783030891251
024 7 _a10.1007/978-3-030-89125-1
_2doi
040 _aTR-AnTOB
_beng
_cTR-AnTOB
_erda
060 _aWC 506
072 7 _aMBN
_2bicssc
072 7 _aMED076000
_2bisacsh
072 7 _aMBN
_2thema
096 _aWC506EBK
100 1 _aVelásquez, Germán.
_eauthor.
_4aut
_4http://id.loc.gov/vocabulary/relators/aut
245 1 0 _aVaccines, Medicines and COVID-19
_h[electronic resource] :
_bHow Can WHO Be Given a Stronger Voice? /
_cby Germán Velásquez.
250 _a1st ed. 2022.
264 1 _aCham :
_bSpringer International Publishing :
_bImprint: Springer,
_c2022.
300 _a1 online resource
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aSpringerBriefs in Public Health,
_x2192-3701
505 0 _aChapter 1: COVID-19 Vaccines: Between Ethics, Health and Economics -- Chapter 2: Medicines and Intellectual Property: 10 Years of the WHO Global Strategy -- Chapter 3: Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 -- Chapter 4: Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock -- Chapter 5: Intellectual Property and Access to Medicines and Vaccines -- Chapter 6: The World Health Organization Reforms in the Time of COVID-19 -- Epilogue.
506 0 _aOpen Access
520 _aThis open access book is a collection of research papers on COVID-19 by Germán Velásquez from 2020 and early 2021 that help to answer the question: How can an agency like the World Health Organization (WHO) be given a stronger voice to exercise authority and leadership? The considerable health, economic and social challenges that the world faced at the beginning of 2020 with COVID-19 continued and worsened in many parts of the world in the second-half of 2020 and into 2021. Many of these countries and nations wanted to explore COVID-19 on their own, sometimes without listening to the main international health bodies such as WHO, an agency of the United Nations system with long-standing experience and vast knowledge at the global level and of which all countries in the world are members. In this single volume, the chapters present the progress of thinking and debate — particularly in relation to drugs and vaccines — that would enable a response to the COVID-19 pandemic or to subsequent crises that may arise. Among the topics covered: COVID-19 Vaccines: Between Ethics, Health and Economics Medicines and Intellectual Property: 10 Years of the WHO Global Strategy Re-thinking Global and Local Manufacturing of Medical Products After COVID-19 Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock Intellectual Property and Access to Medicines and Vaccines The World Health Organization Reforms in the Time of COVID-19 Vaccines, Medicines and COVID-19: How Can WHO Be Given a Stronger Voice? is essential reading for negotiators from the 194 member countries of the World Health Organization (WHO); World Trade Organization (WTO) and World Intellectual Property Organization (WIPO) staff participating in these negotiations; academics and students of public health, medicine, health sciences, law, sociology and political science; and intergovernmental organizations and non-governmental organizations that follow the issue of access to treatments and vaccines for COVID-19.
650 0 _aMedicine, Preventive.
650 0 _aHealth promotion.
650 0 _aMedical policy.
650 0 _aVaccines
_xBiotechnology.
650 0 _aBiomaterials.
650 0 _aPublic health.
650 1 4 _aHealth Promotion and Disease Prevention.
650 2 4 _aHealth Policy.
650 2 4 _aBiomaterials-Vaccines.
650 2 4 _aPublic Health.
653 0 _aCOVID-19
710 2 _aSpringerLink (Online service)
830 0 _aSpringerBriefs in Public Health,
_x2192-3701
856 4 0 _uhttps://doi.org/10.1007/978-3-030-89125-1
_3Springer eBooks
_zOnline access link to the resource
942 _2NLM
_cEBK
041 _aeng